Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.73 |
| ▸ | MEN1 | O00255 | 2/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.73 |
| ▸ | AKT1 | P31749 | 2/20 | 0.73 |
| ▸ | LMNA | P02545 | 2/20 | 0.73 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.73 |
| ▸ | PRKCG | P05129 | 1/20 | 0.73 |
| ▸ | PRKCB | P05771 | 1/20 | 0.73 |
| ▸ | PRKCA | P17252 | 1/20 | 0.73 |
| ▸ | PRKCH | P24723 | 1/20 | 0.73 |
| ▸ | PRKCI | P41743 | 1/20 | 0.73 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.73 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.73 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.73 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.73 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.73 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | GMNN | O75496 | 1/20 | 0.73 |
| ▸ | BLM | P54132 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29394546 | 1.00 | ALDH1A1 (0.73) | ALDH1A1MEN1KMT2AAKT1LMNA | |
| SCHEMBL29365750 | 1.00 | ALDH1A1 (0.73) | ALDH1A1MEN1KMT2AAKT1LMNA | |
| SCHEMBL29905581 | 1.00 | ALDH1A1 (0.73) | ALDH1A1MEN1KMT2AAKT1LMNA | |
| SCHEMBL2126087 | 0.97 | ALDH1A1 (0.76) | ALDH1A1MEN1KMT2AAKT1LMNA | |
| SCHEMBL9203174 | 0.97 | ALDH1A1 (0.76) | ALDH1A1MEN1KMT2AAKT1LMNA | |
| SCHEMBL7558240 | 0.97 | ALDH1A1 (0.76) | ALDH1A1MEN1KMT2AAKT1LMNA | |
| SCHEMBL29733465 | 0.96 | ALDH1A1 (0.74) | ALDH1A1MEN1KMT2AAKT1LMNA | |
| SCHEMBL94022 | 0.93 | ALDH1A1 (0.73) | ALDH1A1MEN1KMT2AAKT1LMNA | |
| SCHEMBL93475 | 0.93 | ALDH1A1 (0.73) | ALDH1A1MEN1KMT2AAKT1LMNA | |
| SCHEMBL10565746 | 0.93 | AKT1 (0.83) | ALDH1A1MEN1KMT2AAKT1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3713496-B1 | ULTRASOUND SUSCEPTIBLE MAGNETIC DIRECTED NANO DRUG CARRIER SYSTEM | EGE UNIV (TR) | 2025-07-23 | — | — | EP | claimed |
| WO-2025052180-A2 | LIPIDS AND LIPID NANOPARTICLES | Axelyf ehf. (IS) | 2025-03-13 | — | — | WO | claimed |
| US-20240366747-A1 | UNIVERSAL VACCINE FOR INFLUENZA VIRUS BASED ON TETRAMERIC M2 PROTEIN INCORPORATED INTO NANODISCS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2024-11-07 | — | — | US | claimed |
| US-20240210417-A1 | KIT AND METHOD FOR SCREENING OF ANTIBODY USING GPCR-EMBEDDED NANODISCS | RECEPTECH INC. (KR) | 2024-06-27 | — | — | US | claimed |
| CN-118225864-A | Biosensor based on monolayer self-assembled phospholipid and preparation method and application thereof | 武汉大学 | 2024-06-21 | — | — | CN | claimed |
| CN-113186203-B | Vaccine agent for treating or preventing coronavirus diseases | 斯微(上海)生物科技股份有限公司 | 2022-12-30 | — | — | CN | claimed |
| WO-2022225116-A1 | KIT AND METHOD FOR SCREENING OF ANTIBODY USING GPCR-EMBEDDED NANODISCS | 리셉텍 주식회사 | 2022-10-27 | — | — | WO | claimed |
| CN-114173826-A | Methods for delivering modified RNA encoding VEGF-a polypeptides using lipid nanoparticles and pharmaceutical compositions comprising the same | 阿斯利康(瑞典)有限公司 | 2022-03-11 | — | — | CN | claimed |
| CN-113186203-A | Vaccine agent for treating or preventing coronavirus diseases | 斯微(上海)生物科技有限公司 | 2021-07-30 | — | — | CN | claimed |
| EP-3713496-A2 | ULTRASOUND SUSCEPTIBLE MAGNETIC DIRECTED NANO DRUG CARRIER SYSTEM | Ege Universitesi (TR) | 2020-09-30 | — | — | EP | claimed |
| CN-111356444-A | Lipid nanoparticles for delivery of modified RNA encoding VEGF-A polypeptides | 摩登纳特斯有限公司 | 2020-06-30 | — | — | CN | claimed |
| US-10660854-B2 | Thermostable vaccines based on ether lipids and native viral envelope proteins | BATAVIA BIOSCIENCES INC. (US) | 2020-05-26 | — | — | US | claimed |
| US-20180085313-A1 | Thermostable Vaccines Based On Ether Lipids And Native Viral Envelope Proteins | BATAVIA BIOSCIENCES INC. | 2018-03-29 | — | — | US | claimed |
| US-9655916-B2 | Compositions for external application, containing adenosylcobalamin for improvement of skin diseases | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2017-05-23 | — | — | US | claimed |
| EP-1957087-B1 | COMPOSITIONS FOR EXTERNAL APPLICATION CONTAINING ADENOSYL COBALAMIN FOR USE IN THE TREATMENT OF ATOPIC DERMATITIS | KOREA RES INST CHEM TECH (KR) | 2016-11-02 | — | — | EP | claimed |
| US-20150196581-A1 | COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING ADENOSYLCOBALAMIN FOR IMPROVEMENT OF SKIN DISEASES | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2015-07-16 | — | — | US | claimed |
| US-20130084329-A1 | COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING ADENOSYLCOBALAMIN FOR IMPROVEMENT OF SKIN DISEASES | HANALL BIOPHARMA CO., LTD. (KR) | 2013-04-04 | — | — | US | claimed |
| US-20110135714-A1 | COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING ADENOSYL COBALAMIN FOR IMPROVEMENT OF SKIN DISEASES | KOREAN RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2011-06-09 | — | — | US | claimed |
| US-20090137523-A1 | Compositions for External Application, Containing Adenosyl Cobalamin for Improvement of Skin Diseases | HANALL BIOPHARMA CO., LTD. (KR) | 2009-05-28 | — | — | US | claimed |
| WO-1999066939-A1 | PHOSPHOLIPID VESICLE-TISSUE FACTOR COMPLEX PREPARATIONS AND METHODS OF MAKING AND USING SAME | MARDER VICTOR J (US) | 1999-12-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10660854-B2 | Thermostable vaccines based on ether lipids and native viral envelope proteins | MGLL, DDOST, PLTP | ALDH1A1 4772/4885MEN1 3336/4885KMT2A 3437/4885 |
| US-20150196581-A1 | COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING ADENOSYLCOBALAMIN FOR IMPROVEMENT OF SKIN DISEASES | APOB, ABCB4, AHCY | ALDH1A1 2855/4885MEN1 3010/4885KMT2A 2200/4885 |
| US-20130084329-A1 | COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING ADENOSYLCOBALAMIN FOR IMPROVEMENT OF SKIN DISEASES | APOB, ABCB4, AHCY | ALDH1A1 2855/4885MEN1 3010/4885KMT2A 2200/4885 |
| US-20180085313-A1 | Thermostable Vaccines Based On Ether Lipids And Native Viral Envelope Proteins | MGLL, DDOST, PLTP | ALDH1A1 4772/4885MEN1 3336/4885KMT2A 3437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.